Fentermin

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
Fentermin
(IUPAC) ime
2-metil-1-fenilpropan-2-amin
Klinički podaci
Robne marke Adipex-P, Duromine, Fastin, Inoamin
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 122-09-8
ATC kod A08AA01
PubChem[1][2] 4771
DrugBank DB00191
ChemSpider[3] 4607
KEGG[4] C07438 YesY
ChEMBL[5] CHEMBL8080 YesY
Hemijski podaci
Formula C10H15N 
Mol. masa 149.2328
SMILES eMolekuli & PubHem
Fizički podaci
Tačka topljenja 205 °C (401 °F)
Farmakokinetički podaci
Poluvreme eliminacije 16 do 31 sati
Farmakoinformacioni podaci
Trudnoća ?
Pravni status
Način primene Oralno

Fentermin je stimulans centralnog nervnog sistema i simpatomimetik sa dejstvom i primenom sličnom sa dekstroamfetaminu. On je korišten za tretiranje gojaznosti. Naka od tržišnih imena su: -[Adipex-P i Suprenza. Fentermin je takođe dostupan u kombinacijama sa drugim lekovima, kao što je Qsymia.[6][7][8][9]

Reference[uredi - уреди | uredi izvor]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). "PubChem as a public resource for drug discovery.". Drug Discov Today 15 (23-24): 1052–7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). "Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities". Annual Reports in Computational Chemistry 4: 217–241. doi:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). "Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining". J Cheminform 2 (1): 3. PMID 20331846. doi:10.1186/1758-2946-2-3.  edit
  4. Joanne Wixon, Douglas Kell (2000). "Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG". Yeast 17 (1): 48–55. doi:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). "ChEMBL: a large-scale bioactivity database for drug discovery". Nucleic Acids Res 40 (Database issue): D1100–7. PMID 21948594. doi:10.1093/nar/gkr777.  edit
  6. Bray GA: A concise review on the therapeutics of obesity. Nutrition. 2000 Oct;16(10):953-60. PMID 11054601
  7. Nelson DL, Gehlert DR: Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine. 2006 Feb;29(1):49-60. PMID 16622292
  8. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). "DrugBank 3.0: a comprehensive resource for omics research on drugs". Nucleic Acids Res. 39 (Database issue): D1035–41. PMID 21059682. 
  9. Nucleic Acids Res (2008). "DrugBank: a knowledgebase for drugs, drug actions and drug targets" 36 (Database issue). pp. D901–6. PMID 18048412. 

Spoljašnje veze[uredi - уреди | uredi izvor]

Star of life.svg Molimo Vas, obratite pažnju na važno upozorenje u vezi tema o zdravlju (medicini).